Clinical Trials Browser

Phase 2 × Not yet recruiting × dapagliflozin × Clear all

NCT07310433 2025-12-30

Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06427226 2024-05-23

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Phase 2 Not yet recruiting

Breast Neoplasms